Phase IIa Study to Assess Safety and Efficacy in the Relapsed/Refractory Acute Myeloid Leukemia
Clinical trial NCT06532058 · UNKNOWN
Trial details
- NCT number
- NCT06532058
- Sponsor
- Changzhou Qianhong Bio-pharma Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-10
- Primary completion
- 2025-02-10
- Enrollment
- 53
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.